These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3299121)

  • 41. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release.
    Donati D; Degiannis D; Homer L; Gastaldi L; Raskova J; Raska K
    Nephron; 1991; 58(3):268-75. PubMed ID: 1896091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebral computed tomography in uremic and hemodialyzed patients.
    Cusmano F; Savazzi GM
    J Comput Assist Tomogr; 1986; 10(4):567-70. PubMed ID: 3734196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic changes in diabetic uremic patients on hemodialysis.
    Avram MM; Lipner HI; Sadiqali R; Iancu M; Gan AC
    Trans Am Soc Artif Intern Organs; 1976; 22():412-9. PubMed ID: 951859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uremic frost.
    Mohan D; Railey M
    Kidney Int; 2012 Jun; 81(11):1153. PubMed ID: 22584601
    [No Abstract]   [Full Text] [Related]  

  • 46. Preliminary evaluation of pancreatic islets in rats with experimental uremia and after thyroparathyroidectomy.
    Kasacka I; Azzadin A; Sawicki B
    Folia Histochem Cytobiol; 2002; 40(2):179-80. PubMed ID: 12056634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetes in hemodialysis: study of differential factors].
    Sanz París A; Lou Arnal LM; Gutiérrez Colón JA; Alvarez Lipe A; Albero Gamboa R
    An Med Interna; 1998 Apr; 15(4):183-8. PubMed ID: 9608060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients.
    Lim WH; Kireta S; Leedham E; Russ GR; Coates PT
    Kidney Int; 2007 Nov; 72(9):1138-48. PubMed ID: 17728708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uremia, dialysis and aluminium.
    Di Paolo N; Masti A; Comparini IB; Garosi G; Di Paolo M; Centini F; Brardi S; Monaci G; Finato V
    Int J Artif Organs; 1997 Oct; 20(10):547-52. PubMed ID: 9422488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.
    Narita I; Alchi B; Omori K; Sato F; Ajiro J; Saga D; Kondo D; Skatsume M; Maruyama S; Kazama JJ; Akazawa K; Gejyo F
    Kidney Int; 2006 May; 69(9):1626-32. PubMed ID: 16672924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV; Khomenko VF
    Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
    Redaelli B; Salvadeo A; Imbasciati E; Ponticelli C
    Arch Ital Urol Nefrol; 1967; 39(6):459-67. PubMed ID: 5606789
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells.
    Plum J; Fleisch MC; Razeghi P; Fusshöller A; Lordnejad MR; Grabensee B
    Kidney Blood Press Res; 2002; 25(4):195-201. PubMed ID: 12424420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zinc tolerance tests in chronic uremia.
    Antoniou LD; Shalhoub RJ; Elliot S
    Clin Nephrol; 1981 Oct; 16(4):181-7. PubMed ID: 7296977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis.
    Galetta F; Cupisti A; Franzoni F; Morelli E; Caprioli R; Rindi P; Barsotti G
    Blood Purif; 2001; 19(4):395-400. PubMed ID: 11574736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [An echocardiographic study of cardiac function in chronic hemodialysis patients].
    Okada Y
    Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):765-74. PubMed ID: 2585830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.